Dr Joanna Osmanska
- Honorary Clinical Research Fellow (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)
Docherty, K. F. et al. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82(2), pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011) (PMID:37407113)
Hawkins, N. M., Osmanska, J. and Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22(5), pp. 868-870. (doi: 10.1002/ejhf.1803) (PMID:32227573)
Osmanska, J. and Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36(2), pp. 137-146. (doi: 10.1007/s40266-018-0625-4) (PMID:30535931)
Osmanska, J., Hawkins, N. M., Toma, M., Ignaszewski, A. and Virani, S. A. (2018) Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Failure, 5(4), pp. 668-674. (doi: 10.1002/ehf2.12297) (PMID:29938922) (PMCID:PMC6073034)
Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)
Docherty, K. F. et al. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82(2), pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011) (PMID:37407113)
Hawkins, N. M., Osmanska, J. and Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22(5), pp. 868-870. (doi: 10.1002/ejhf.1803) (PMID:32227573)
Osmanska, J. and Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36(2), pp. 137-146. (doi: 10.1007/s40266-018-0625-4) (PMID:30535931)
Osmanska, J., Hawkins, N. M., Toma, M., Ignaszewski, A. and Virani, S. A. (2018) Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Failure, 5(4), pp. 668-674. (doi: 10.1002/ehf2.12297) (PMID:29938922) (PMCID:PMC6073034)